D.E. Shaw & Co
NUTX

D.E. Shaw & Co’s Nutex Health NUTX Stock Holding History

D.E. Shaw & Co’s Portfolio NUTX Stock Details NUTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3,736
Closed -$236K – 4414
2023
Q2 		$236K Buy
+3,736
New +$320K ﹤0.01% 3686
2022
Q3 		– Sell
-292
Closed -$141K – 5418
2022
Q2 		$141K Buy
+292
New +$344K ﹤0.01% 4662

Other funds holding NUTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SWM
Scissortail Wealth Management Tulsa, Oklahoma $498M AUM 20.41% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

D.E. Shaw & Co's NUTX Position: Q3 2023 in Review

D.E. Shaw & Co sold out of Nutex Health (NUTX) in Q3 2023, closing a stake of 3,736 shares — an estimated $236K sold.

D.E. Shaw & Co first reported a position in NUTX in Q2 2022 and held it in 2 quarters. The position peaked at $236K in Q2 2023. 59 funds tracked by Wall St. Rank hold NUTX as of Q3 2023.

  • D.E. Shaw & Co reported no remaining Nutex Health position as of Q3 2023 after selling out during the quarter.
  • D.E. Shaw & Co sold 3,736 Nutex Health shares in Q3 2023, an estimated $236K.
  • D.E. Shaw & Co first reported a position in Nutex Health in Q2 2022 and held it in 2 quarters.
  • D.E. Shaw & Co's Nutex Health position peaked at $236K in Q2 2023.
  • 59 funds tracked by Wall St. Rank held Nutex Health as of Q3 2023.

Based on D.E. Shaw & Co's 13F filing for Q3 2023, filed 14 Nov 2023.